ReviewBiomarker research2018
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies.
Rosemarie Tremblay-LeMay et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this papercites it